Delivery Order SPE2D021DA002-SPE2D325F0924

Award Date 10/28/24
Potential Completion Date 10/29/24
Potential Value $5.9K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,968.40, was issued by the Defense agency's Medical Supply Chain to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Engerix-B 20 MCG/ML SYRN, a pharmaceutical product, with a completion date of April 11, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract, valued at up to $4,999,999, with the Defense Logistics Agency under the SPE2DB program. This...
This is a federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, by the Defense Logistics Agency (DLA). The $10,912.32 firm fixed-price delivery order is for the supply of ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This IDC allows the DLA to issue delivery orders for a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,603.16 firm fixed-price delivery order is for the supply of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine, with no set-aside designation. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,968.40 contract is for the delivery of 4,566,322,435 units of ENGERIX-B 20 MCG/ML SYRN, a specialized pharmaceutical product, with a period of performance through November 5, 2024. DMS Pharmaceutical Group holds a single-award Indefinite Delivery Contract (IDC) with the DLA under...
This delivery order for $2,362.08 was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of ENGERIX-B 20 MCG/ML SYRN, a hepatitis B vaccine, to the Defense Logistics Agency (DLA) Medical Supply Chain. The order, placed under the DLA's SPE2DB program, has a firm fixed price and an ultimate completion date of July 12, 2024. DMS Pharmaceutical Group specializes in providing a wide range...
This is a $1,969.50 firm fixed-price delivery order contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is for the provision of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product, to the Defense Logistics Agency (DLA), the funding agency. The contract has an ultimate completion date of May 30, 2025 and was awarded on May 27, 2025. DMS Pharmaceutical Group Inc. is an experienced federal contractor, holding a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,969.50 firm fixed-price delivery order is for the supply of ENGERIX-B 20 MCG/ML SYRN, a hepatitis B vaccine. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at $499,999,999 and valid through November 2026. The IDC...
This federal contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The $5,596.65 firm fixed price delivery order is for the pharmaceutical product ENGERIX-B 20 MCG/ML SYRN. DMS Pharmaceutical Group holds various contracts and indefinite delivery vehicles (IDVs) with DLA to provide pharmaceuticals and medical supplies to support military treatment facilities worldwide. This delivery order is...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,115.64 firm-fixed-price contract is for the supply of the pharmaceutical product "ENGERIX-B 20 MCG/ML SYRNML" with a completion date of June 18, 2024. The award is under a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit woman-owned small business located in Park Ridge, Illinois. The $7,873.60 order is for ENGERIX-B 20 MCG/ML syringes and is part of a larger $4,999,999 indefinite delivery vehicle (IDV) contract with DLA under the SPE2DB program. This IDV enables DLA to issue delivery orders for a broad range of pharmaceutical items to fulfill the recurring medical supply needs of...
  • SPE2D021DA002
    Indefinite Delivery Contract
  • SPE2D021DA002-SPE2D325F0924
    Delivery Order

This federal contract award, valued at $5,905.20, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is a firm fixed-price delivery order for the supply of ENGERIX-B 20 MCG/ML SYRN, a pharmaceutical product, with an ultimate completion date of October 29, 2024.

DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 with the DLA under the SPE2DB program, which allows the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. This delivery order is not associated with any set-aside designation, enabling DMS Pharmaceutical Group Inc. to leverage its status as a woman-owned small business to secure direct federal awards across multiple product categories and medical domains.

Generated 2/2/25, 12:05 AM